Evaluation of a panel of therapeutic antibody clinical candidates for efficacy against SARS-CoV-2 in Syrian hamsters

The COVID-19 pandemic spurred the rapid development of a range of therapeutic antibody treatments. As part of the US government's COVID-19 therapeutic response, a research team was assembled to support assay and animal model development to assess activity for therapeutics candidates against SAR...

Descripción completa

Detalles Bibliográficos
Autores principales: Cong, Yu, Mucker, Eric M., Perry, Donna L., Dixit, Saurabh, Kollins, Erin, Byrum, Russ, Huzella, Louis, Kim, Robert, Josleyn, Mathew, Kwilas, Steven, Stefan, Christopher, Shoemaker, Charles J., Koehler, Jeff, Coyne, Susan, Delp, Korey, Liang, Janie, Drawbaugh, David, Hischak, Amanda, Hart, Randy, Postnikova, Elena, Vaughan, Nick, Asher, Jason, St Claire, Marisa, Hanson, Jarod, Schmaljohn, Connie, Eakin, Ann E., Hooper, Jay W., Holbrook, Michael R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060192/
https://www.ncbi.nlm.nih.gov/pubmed/37003305
http://dx.doi.org/10.1016/j.antiviral.2023.105589

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060192/
https://www.ncbi.nlm.nih.gov/pubmed/37003305
http://dx.doi.org/10.1016/j.antiviral.2023.105589

Ejemplares similares